Contaminants in Buildings and Occupied Spaces as Risk Factors forOccupant Symptoms in U.S. Office Buildings: Findings from the U.S. EPABASE Study by Mendell, M.J. et al.
  
 
 
 
 
 
 
 
 
  Contaminants in Buildings and Occupied Spaces as  
  Risk Factors for Occupant Symptoms in U.S. Office  
  Buildings:  Findings from the U.S. EPA BASE Study 
 
 
 
M.J. Mendell1, A. Mirer1, Q. Lei-Gomez2 
 
 
1Lawrence Berkeley National Laboratory 
Environmental Energy Technologies Division 
Indoor Environment Department 
Berkeley, CA 94720 
 
2 Harvard University School of Public Health 
Boston, MA 
 
 
 August 2007 
 
 
 
  This work was supported by the Indoor Environments Division, Office of  
  Radiation and Indoor Air, Office of Air and Radiation of the U.S.   
  Environmental Protection Agency through interagency agreement   
  DW8992169501-1 with the U.S. Department of Energy under Contract  
  Agreement No. DE-AC02-05CH11231. 
 
LBNL 63370 
  
 
 
     
Disclaimer 
 
This document was prepared as an account of work sponsored by the United States Government. While 
this document is believed to contain correct information, neither the United States Government nor any 
agency thereof, nor The Regents of the University of California, nor any of their employees, makes 
any warranty, express or implied, or assumes any legal responsibility for the accuracy, completeness, 
or usefulness of any information, apparatus, product, or process disclosed, or represents that its use 
would not infringe privately owned rights. Reference herein to any specific commercial product, 
process, or service by its trade name, trademark, manufacturer, or otherwise, does not necessarily 
constitute or imply its endorsement, recommendation, or favoring by the United States Government or 
any agency thereof, or The Regents of the University of California. The views and opinions of authors 
expressed herein do not necessarily state or reflect those of the United States Government or any 
agency thereof, or The Regents of the University of California. 
 
Ernest Orlando Lawrence Berkeley National Laboratory is an equal opportunity employer. 
 
LBNL-63370 
 
 
 
 
 
 
 
 
Contaminants in Buildings and Occupied Spaces as Risk Factors for Occupant Symptoms 
in U.S. Office Buildings: Findings from the U.S. EPA BASE Study 
 
M.J. Mendell1, A. Mirer1, Q. Lei-Gomez2 
 
1 Lawrence Berkeley National Laboratory, Indoor Environment Dept., Berkeley;  
2 Harvard University School of Public Health, Boston 
 
 
 
 
 
 
 
Corresponding author: 
Mark J. Mendell 
Lawrence Berkeley National Laboratory 
Indoor Environment Department 
1 Cyclotron Rd., MS 90-3058 
Berkeley, CA 94720, USA 
Phone: 1-510-486-5762 
email: mjmendell@lbl.gov 
 
Keywords:  
indoor air quality; building-related symptoms; sick building syndrome; cleaning; sources 
 
Acknowledgements 
This work was supported by the Indoor Environments Division, Office of Radiation and Indoor 
Air, Office of Air and Radiation of the U.S. Environmental Protection Agency through 
interagency agreement DW8992169501-1 with the U.S. Department of Energy.  Conclusions in 
this paper are those of the authors and not necessarily those of the U.S. Environmental Protection 
Agency.  We thank Michael Bates and David Lorenzetti for review of the draft manuscript.  
  4 
 
 
Contaminants in Buildings and Occupied Spaces as Risk Factors for Occupant Symptoms 
in U.S. Office Buildings: Findings from the U.S. EPA BASE Study 
 
 
Abstract   
 
Background:  Nonspecific building-related symptoms among occupants of modern office 
buildings worldwide are common and may be associated with important reductions in work 
performance, but their etiology remains uncertain.  Most reported research into environmental 
risk factors for these symptoms has focused on ventilation system-related factors, dampness, and 
particle removal through filtration and cleaning, with relatively few studies of other potential 
sources of indoor contaminants.     
Methods: We analyzed data collected by the U.S. Environmental Protection Agency 
(EPA) from a representative sample of 100 large U.S. office buildings – the Building Assessment 
and Survey Evaluation (BASE) study – using multivariate-adjusted logistic regression models 
with generalized estimating equations.  We estimated odds ratios (ORs) and 95% confidence 
intervals (CIs) for associations between seven building-related symptom outcomes and a diverse 
set of potential indoor and outdoor sources for indoor pollutants.  
Results:  Although most of the investigated risk factors showed no apparent association 
with building-related symptoms, some interesting associations resulted.  Increased prevalence of 
symptoms was associated with carpets older than one year (lower respiratory symptoms), non-
carpeted floors (upper and lower respiratory symptoms), older furniture (eye and skin 
symptoms), infrequent vacuuming (upper respiratory, eye, and skin symptoms and headache), 
and masonry exterior walls (cough, eye symptoms, and fatigue/concentration difficulty).   
 Discussion: For the many potential risk factors assessed, almost none had been 
investigated previously, and many associations found here may have been by chance.  Additional 
confirmatory research focused on risk factors initially identified here is needed, using more 
objective measures of health outcomes and risk factors or exposures.  
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Background 
Complaints of respiratory, eye, and skin symptoms, headache, and fatigue have been reported by 
occupants of office buildings in many countries since the 1970s.  Explaining or preventing these 
problems has been difficult.  Although indoor exposures causing these symptoms have not been 
identified, researchers have identified environmental “risk factors” that are correlated with higher 
prevalences of symptoms in buildings, and thus may be proxies for unidentified causal 
exposures.  These risk factors include the presence of air-conditioning systems (Seppanen and 
Fisk 2002), contaminated components of heating, ventilating, and air-conditioning (HVAC) 
systems (Mendell, Naco et al. 2003), low ventilation rates (Seppanen, Fisk et al. 1999), and 
dampness or visible mold in buildings (Park, Schleiff et al. 2004; Mendell, Cozen et al. 2006). 
 
The Building Assessment and Survey Evaluation (BASE) study, conducted by the U.S. 
Environmental Protection Agency, is the largest available study of building environments and 
occupant symptoms in a representative set of U.S. office buildings.  This paper presents findings 
from an analysis of risk factors in the BASE data involving potential contaminant sources, 
related to either the buildings, the occupied spaces, or the contents, that had been determined by 
inspection or interview.  Risk variables in the BASE data assessed in this analysis include those 
related to the building envelope, indoor surface materials, furnishings and equipment, and 
practices of housekeeping, building maintenance, and building operation.  Most of these risk 
factors have not been assessed in prior analyses of indoor contaminants in the BASE data, which 
focused primarily on moisture-related contamination (Mendell, Cozen et al. 2006).   
 
The analyses reported here primarily explored previously untested hypotheses about specific 
sources of indoor contaminants as causing various irritant, allergic, or toxic responses in 
occupants.  We therefore investigated correlations of risk variables with increased prevalence of 
work-related symptoms, including lower and upper respiratory symptoms, cough, eye symptoms, 
fatigue/ difficulty concentrating, headache, and skin symptoms.  Because many of these risk 
factors were correlated with each other, and because many other environmental and non-
environmental factors in office buildings are known to be associated with symptom reporting, we 
used multivariate models to estimate the independent associations with building-related 
symptoms (BRS) of these risk factors for indoor sources of contaminants.   
 
Methods 
The study has been described by Brightman and Moss (2000), and full details of the study 
protocol published elsewhere (U.S. Environmental Protection Agency 2003).  Briefly, data in the 
BASE study were collected by the U.S. EPA from 100 representative office buildings selected 
from geographic regions throughout the U.S. during 1994-1998.  Within each of the 100 
buildings, the study randomly selected a “study space” with, if possible, at least 50 occupants 
and served by no more than two ventilation air-handling units.  As only one study space was 
selected per building, the terms “building” and “study space” are used here interchangeably.  
Environmental data were collected using standardized procedures including building inspections, 
interviews with facility managers, and a broad range of environmental measurements.  Personal 
data were collected from questionnaires distributed to all occupants of each study space.  Each 
building was studied once, in either summer or winter.   
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Outcomes 
The questionnaire asked each respondent about the frequency of occurrence of various symptoms 
during the last four weeks at work, and also whether each symptom was better or worse on days 
when the respondent was away from the building.  A specific symptom was considered “weekly, 
building-related” for a respondent if the symptom was reported as having occurred in the 
building at least one day per week over the four weeks prior to the survey, and as having 
improved away from the building.  For analyses, we used seven types of weekly, BRS outcomes, 
some defined as the presence of at least one of several specific weekly, building-related 
symptoms: lower respiratory (wheeze, shortness of breath, or chest tightness), cough, upper 
respiratory (stuffy or runny nose, sneezing, or sore or dry throat), eye symptoms (dryness, 
irritation, or itching), fatigue or difficulty concentrating, headache, and skin symptoms (dryness, 
irritation, or itching).   
 
Risk Factors 
These analyses investigated potential risks associated with exposure to contaminants from a 
variety of sources related to the indoor workplace, including building characteristics, cleaning 
materials and practices, indoor materials and renovation, outdoor pollutants, pesticide 
application, and “special uses” (i.e., specific unusual uses of office space that might produce 
unusual contaminants, such as graphics shops or kitchens).  Potential risk factors of interest are 
listed in Table 1.  We will use the term “risk factor” here to indicate factors that may potentially 
be markers for increased risk of health outcomes (rather than, as it is sometimes used, to indicate 
factors already identified as markers for increased risk).  Some of the original variables were 
combined into composite or index variables, or omitted, due to missing, inconsistent, or illogical 
data values, insufficient variation, or strong intercorrelations.  Continuous variables were 
converted to categorical variables for the analyses, as using a continuous independent variable 
forces an assumption of a linear relationship.  Some variables described sources related to entire 
study buildings, and some related to specific spaces in the buildings.  We considered either or 
both of these as seemed most appropriate.   
 
Some variable categories were combined when too few buildings had a particular characteristic.  
For example, neighboring land uses were classified as agricultural or industrial for so few 
buildings that we combined these into the category other.  Variables describing materials for 
each specific type of indoor surface or furnishing were complex: for each type of 
surface/furnishing (e.g., walls, partitions, movable furniture) perhaps five or more specific 
materials (e.g., wood, painted wallboard, cloth, metal, glass, other) could each be specified as 
primary, secondary, or other.  We generally considered only materials described as primary for 
each surface or furnishing.  When appropriate based on prior hypotheses, primary materials were 
grouped on the basis of relevant properties (such as level/type of potential emissions).  As an 
example of a variable created for analyses, the variable on carpet combined information on 
primary floor coverings with a variable on carpet renovation.    
 
Confounding Variables 
Many factors were considered as potential confounders of the associations between contaminant 
exposure and weekly building-related symptoms.  Potential environmental confounders included 
temperature (the product of number of degrees over 20°C and number of hours at each level, in 
quartiles (Apte, Fisk et al. 2000)), mean humidity ratio (a measure of absolute humidity, in 
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quartiles), ventilation rate (as estimated from volumetric flow measures (Mendell, Lei et al. 
2005)), floor area in study space per operable window, average hours of ventilation per weekday, 
and season during which each building was studied.  Personal variables considered as potential 
confounders included subject’s age, gender, smoking status, job category, level of education, job 
satisfaction, job demand, job conflict, hours worked weekly, years worked in the building, 
workstation location, hours worked at a computer daily, photocopier use, comfort of chair, 
comfort of desk, and histories of hay fever, dust allergy, mold allergy, eczema, and asthma. 
 
Analysis Methods 
All analyses were performed using SAS version 8 (SAS Institute Inc. 2002).  Appendix 1 
provides details of the analytic procedures.  In brief, descriptive univariate analysis was 
performed first, and variables lacking sufficient variation or completeness were re-categorized or 
excluded.  Next, the crude association of each of the seven symptom outcomes with each of the 
remaining risk factor variables was estimated.  Those with even moderate associations were 
retained for each outcome, and subjected as a group to “backward” selection (see (3) in 
Appendix 1).  Potential confounders were then chosen for inclusion in these models containing 
selected risk factors based on changes of at least 10% in any risk estimate.  The resulting models 
produced the initial multivariate adjusted estimates.  This was followed by reconsideration for 
inclusion, in models including the chosen confounders, of any risk factors excluded during prior 
stages of modeling.  Finally, for each outcome, the chosen risk factors and confounders were 
included in a logistic regression model with generalized estimating equations (GEE) to account 
for potential clustering of subjects within the same building.   
 
Estimates from bivariate analyses and final multivariate adjusted models with GEE are presented 
as odds ratios (ORs) and 95% confidence intervals (CIs).  An odds ratio greater than one 
indicates a greater prevalence in the group of subjects with the risk factor than in those without 
the risk factor, while an odds ratio less than one indicates the reverse.  An odds ratio of 1.0 
indicates approximately equal prevalences in both groups, that is, no association between the risk 
factor and the symptom outcome.  Estimates from multivariate models may be interpreted as the 
relationship of the prevalences in subjects with and without the risk factor, independent of all 
other risk factors and confounding factors present in the model.   
 
Results  
BASE data were available from 4,326 building occupants in 100 study spaces/buildings.  The 
overall response rate for the occupant questionnaire was 85%. Overall prevalence of the seven 
symptom outcome definitions in the entire survey population ranged from 4.2% for lower 
respiratory symptoms to 20.9% for upper respiratory symptoms.  Prevalence of each outcome 
varied substantially among the 100 buildings.   
 
The study population has been described elsewhere in more detail (Brightman and Moss 2000).  
Among the respondents, 66% were female, 61% were between the ages of 30 and 49, and 15% 
were current smokers.  Respondents’ job categories were: 35% professionals, 34% clerical, 17% 
managers, and 14% technical.  Approximately 46% of respondents had less than a college 
degree, and 54% had at least an undergraduate degree.   
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Descriptive (univariate) analysis 
We organized the risk factors at the building and study space levels into two categories: physical 
characteristics and pollutant sources.  Table 1 lists the risk factors of initial interest.   
 
Table 2 shows the risk factor variables after initial exclusion, combination, and recategorization, 
along with the number of buildings or study spaces in each category of the risk factor variables.  
The 50 risk variables are organized under the following headings (all pertain to test spaces unless 
noted): indoor materials (7 variables), cleaning (17 variables), pesticides (5 variables), special 
uses in study spaces (6 variables), special uses in buildings (4 variables), building characteristics 
(5 variables), and outdoor sources near buildings (6 variables).  Almost all variable categories 
contained at least five buildings.  Numbers for each variable may not add to 100 due to missing 
values.   
 
Unadjusted (bivariate) analyses 
Table 2 also shows bivariate associations with outcomes for the risk factor variables selected or 
created after univariate analyses, unadjusted for any confounding involving correlation with each 
other or with personal variables.  We observed two primary patterns among some of the 50 risk 
factors assessed: 1) generally lower prevalence of most symptoms, or 2) generally higher 
prevalence of most symptoms, both including varying numbers of statistically significant 
differences.  Other risk factors showed small associations in both directions with occasional 
significant changes in at most one symptom.  We will not mention patterns of change that were 
generally around 10% or less.  
 
Factors that were associated in unadjusted models to generally higher prevalence of most 
symptoms included: carpet greater than one year old as primary flooring, or no primary carpet, 
relative to carpet replaced within the prior year; cloth partitions, furniture, or paint greater than 
one year old, relative to these materials renovated within the prior year; office cleaning or dry 
mopping during occupied hours; vacuuming less frequently (weekly-to-monthly vs. daily); dry 
mopping more frequently; relatively infrequent application of interior pesticide, or especially 
with no available information on frequency, relative to no application; exterior pesticide 
application four or more months prior, relative to no application; any past interior pesticide 
applications, relative to no past applications, especially if four or more months prior; interior 
pesticide applications that include the test space; presence of a computer room; presence of 
loading docks; study spaces whose buildings contained smoking lounges elsewhere within the 
building (relative to spaces with no smoking allowed in the buildings); nearby heavy vehicular 
traffic or nearby emergency generators; and buildings constructed between 1946 and 1975 
(relative to the oldest buildings, constructed before 1946).   
   
Factors that were associated in unadjusted models to generally lower prevalence of most 
symptoms included: presence of systems furniture; less frequent wet mopping (weekly-to-
monthly relative to none); exterior pesticide application daily to monthly, relative to no 
application; presence of a kitchenette in the study space; buildings in “other” neighborhoods, 
including industrial and agricultural neighborhoods, relative to those in residential 
neighborhoods; buildings with glass/metal curtain or “other” kinds of exterior walls, relative to 
masonry exterior walls; and the most recently constructed buildings (1976-1996, relative to the 
oldest buildings, constructed before 1946).   
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For each symptom outcome model, bivariate model outcomes determined which variables were 
included in initial risk selection models (not shown), using criteria described in Appendix 1.  All 
risk factors then retained in each risk selection model were kept throughout the construction of 
final models for that outcome.   
 
Adjusted analyses 
Table 3 provides estimates from the final multivariate logistic regression/GEE models, along 
with the number of individuals and buildings included in each final model.  The Hosmer-
Lemeshow goodness-of-fit p-values for all final models produced by the basic algorithm had p-
values >0.05, without requiring additional alteration to improve fit.   
 
Spaces with carpet older than one year as primary flooring, relative to those with carpets 
replaced during the prior year, had significantly increased prevalence of lower respiratory 
symptoms, with OR=1.87.  Spaces with only primary flooring materials other than carpet, 
relative to spaces with newer carpet, had significantly increased prevalence of lower and upper 
respiratory symptoms, with ORs= 2.34 and 2.24, respectively.  Spaces with furniture older than 
one year, relative to those with furniture replaced within the prior year, were associated with 
significant increases in eye and skin symptoms, with ORs of 1.42 and 2.06, respectively.  Cloth 
partitions were not substantially associated with any symptom, and recent painting was not 
included in any final symptom model.    
 
Any scheduled wet mopping was associated with some reduction in headache, including a 
significant reduction for weekly-to-monthly frequency, with OR=0.46.  Weekly-to-monthly 
vacuuming, relative to daily, was associated with significantly increased prevalence of upper 
respiratory symptoms, eye symptoms, and headache, and marginally with skin symptoms, with 
ORs of 1.38, 1.30, 1.42, and 1.37, respectively.  Use of window cleaner was associated with a 
significant reduction in upper respiratory symptoms, OR=0.72, and use of bathroom cleaner was 
associated with increased lower respiratory symptoms, OR=2.29.  Application of exterior 
pesticide semiquarterly to annually, relative to none, was associated with a significant increase in 
upper respiratory symptoms, OR=1.44, but daily to monthly, or unscheduled applications, were 
not.  Application of interior pesticides four or more months prior, relative to no past application, 
was associated with significant increases in upper respiratory symptoms, fatigue/difficulty 
concentrating, and headache, with ORs of 1.79, 1.70, and 1.57 respectively.  Applications up to 
three months prior were associated with smaller increases in the same symptoms.     
 
Among special uses, presence of a kitchenette was associated with significantly reduced 
fatigue/difficulty concentrating and marginally significantly reduced cough, with ORs of 0.70 
and 0.75 respectively.  Relative to masonry exterior walls, other exterior wall materials were 
mostly associated with substantial decreases in cough, eye symptoms, and fatigue/difficulty 
concentrating.  For instance, glass/metal curtain walls were associated with significantly reduced 
ORs for cough and eye symptoms of 0.47 and 0.64.  Relative to buildings in which smoking was 
completely prohibited, study spaces in which smoking was permitted in the test space were 
associated with increased skin symptoms, OR=1.84.   
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Discussion  
The EPA BASE data allow the first broad assessment in U.S. office buildings of the associations 
between suspected indoor environmental risk factors and nonspecific symptoms in office 
workers.  The present analysis primarily investigated factors not previously assessed for 
associations with symptoms: features or practices, not related to the ventilation system, that can 
be determined by inspection or interview and that may indicate contaminant sources correlated 
with symptoms.     
.   
These exploratory analyses were intended to investigate associations between symptoms and a 
wide variety of potential sources, indoor or outdoor, of pollutants in the office environment, that 
could be ascertained from inspection or interview.  Little prior investigation has been reported on 
associations between acute symptoms and this set of potential contaminant sources.  While 
unadjusted estimates showed many of the investigated risk factors to have associations with most 
of the symptoms assessed, multivariate adjusted estimates showed many fewer associations.  
This was presumably because unadjusted estimates included associations better explained by 
other correlated risk factors.  Still, several risk factors had statistically significant or 
nonsignificant but substantial associations with multiple symptoms.  Others had associations 
with one symptom, which may have been due to chance.  We consider ORs associated with 
categories containing five or fewer buildings, even if significant or large, to be too unstable for 
interpretation.   
 
Carpets are sometimes considered potential sources for exposure to accumulated or amplified 
dust mites, microorganisms, and particles (Allermann, Wilkins et al. 2006), but they may also be 
“sinks” for these contaminants and, by collecting and retaining them, reduce related exposures.  
Prior studies have been inconsistent about whether carpets are risk factors for adverse health.  
For instance, studies have shown carpets to be associated with increased risk of asthma 
(Mohamed, Ng'ang'a et al. 1995; Jaakkola, Ieromnimon et al. 2006); decreased risk of asthma 
(Zock, Jarvis et al. 2002), respiratory symptoms (Skorge, Eagan et al. 2005; Trevillian, Ponsonby 
et al. 2005), and eczema (Palmer, Valinsky et al. 1999); or no effects on asthma (Voute, Zock et 
al. 1994). The BASE study is not ideal for investigating risks associated with carpet, as 91 of 100 
study spaces had carpet as a primary floor covering. The reduced prevalence of lower and upper 
respiratory symptoms associated in the BASE study with presence of carpet, especially newer 
carpet, suggests a protective effect (if other unknown confounding factors do not explain this).  
This does not agree with some prior reports (Jaakkola, Parise et al. 2004).  On the other hand, the 
findings suggest that any benefit may diminish over time, perhaps as the carpet inevitably 
accumulates particles, including fungi and allergens, with normal use and maintenance 
(Dybendal, Vik et al. 1989; Dybendal, Vik et al. 1990; Dybendal and Elsayed 1992; Cho, 
Reponen et al. 2006; Giovannangelo, Gehring et al. 2007).  Unfortunately, the data did not 
include specific age of carpets older than one year.   
 
We saw little other association between symptoms and different types of office furnishings or 
surface materials in multivariate models, except that the presence of older furniture was 
associated with increased prevalence of eye and skin symptoms.  The different symptoms 
associated with less recently replaced carpets and furniture suggests a lack of a common 
underlying exposure or biologic mechanism.  Findings here did not corroborate findings in some, 
but not all, prior studies by others of increased risk of symptoms or respiratory health effects 
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from presence of fleecy or high-surface-area materials such as carpets or cloth partitions (e.g., 
(Skov, Valbjorn et al. 1990; Jaakkola, Tuomaala et al. 1994; Jaakkola, Oie et al. 1999; Zock, 
Jarvis et al. 2002; Skorge, Eagan et al. 2005; Jaakkola, Ieromnimon et al. 2006)).   
 
Office cleaning activities are intended to improve cleanliness and appearance of indoor surfaces; 
however, they may increase, immediately and for some time after cleaning, indoor levels of 
volatile organic compounds and airborne dust (Wolkoff, Schneider et al. 1998).  We found no 
evidence in the BASE data that any specific kind of cleaning activity during work hours resulted 
in consistent increase in exposures causing any building-related symptoms.  Regarding scheduled 
frequencies for specific types of cleaning, only two were associated with changes in prevalence 
of any symptom.  Less frequently scheduled vacuuming was associated with increased upper 
respiratory, eye, headache, and skin symptoms.  While the category of vacuuming “as needed or 
missing” was not associated with similar increases, this is not necessarily inconsistent, as the 
category included only a small number of buildings, including several with no information.  The 
association found between any scheduled wet mopping and significant reductions in headache is 
difficult to interpret.  Ninety-one BASE study spaces had carpet as the primary floor covering, 
which could not be wet-mopped.  Only eight study spaces, however, were reported to have no 
wet mopping, presumably because bathroom floors were generally wet-mopped, as well as any 
secondary hard surfaces such as hallways. While the estimates might suggest that performing wet 
mopping of hard-surface floors in office spaces reduces risk of headache, perhaps due to removal 
of some contaminants, it is unclear whether this association with an activity in secondary spaces 
is meaningful. 
 
Only one kind of cleaning product was associated in the BASE data with a symptom increase 
among office workers: bathroom cleaner was associated with increased lower respiratory 
symptoms.  While this would be consistent with an irritant effect of a repeatedly used cleaning 
product in spaces that all workers are likely to enter, high average exposures would not be 
expected from repeated but short-term presence in a room in which a cleaning product had been 
previously applied.  Moreover, it seems likely that all office buildings use some kind of 
bathroom cleaning products, whether or not reported in this study.  Still, there is evidence that 
professional cleaners are at increased risk for asthma from exposure to cleaning products they 
use, especially bleach (Zock, Kogevinas et al. 2001; Jaakkola and Jaakkola 2006; Macaira, 
Algranti et al. 2007).  The association of window cleaner with reduced prevalence of headache 
but not other symptoms may be a chance association.    
 
The evidence for adverse acute effects on occupants of exterior pesticide application is not 
persuasive, as only relatively infrequent application was associated with some increase in just 
upper respiratory symptoms, and more frequent application had little association with that 
symptom.  Frequency of interior pesticide application was not associated with symptoms in 
multivariate models.  Although previous interior pesticide application, four or more months 
prior, was associated with increase in three symptoms, including upper respiratory, relative to no 
prior application, a more recent application was not associated with as large an increase.  The 
evidence for symptoms resulting from exterior or interior pesticide applications in these office 
buildings is apparently inconsistent.       
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It is not clear why masonry exterior walls were associated with higher prevalence of cough, eye 
symptoms, and fatigue/concentration relative to glass/metal curtain walls and some other wall 
materials.  One possible explanation might be a greater probability of water incursion through 
masonry walls into indoor spaces, due to the high permeability of masonry materials or the 
presence of cracks or deteriorated mortar.  (For discussions of moisture problems related to 
masonry exterior walls, see http://epdweb.engr.wisc.edu/aecarticles/rsrc04.lasso and http://irc.nrc-
cnrc.gc.ca/pubs/cp/wal1_e.html.)  That office spaces in which smoking was permitted had an increase 
only in skin symptoms is not consistent with current knowledge of the effects of secondhand 
smoke.  We assume the finding is a result of confounding or chance (see discussion below).  This 
finding also has limited practical implications, as tobacco smoking is allowed in increasingly 
fewer U.S. office buildings.    
 
Limitations 
The BASE study, although a large and unusually comprehensive collection of data from a 
representative set of U.S. office buildings, has many limitations for epidemiologic analyses 
aimed at understanding causes of building-related health effects.  The study, designed around 
1990, was conducted primarily to obtain normative data rather than to test specific a priori 
hypotheses.  Many building features of current research interest cannot be investigated in these 
data because of insufficient representation or variation in the study buildings.  In addition, the 
BASE study collected limited information on a large number of environmental characteristics of 
the study buildings, so the data often lack sufficient detail to answer current hypothetical 
questions.  It is also inherently difficult to study environments as complex as large buildings. 
Although the BASE study contained responses from over 4,000 individual occupants of the study 
spaces, most environmental data can be analyzed only at the level of the 100 study spaces or 
buildings, providing limited variation for analysis of the environmental factors.  Perhaps most 
important, the environmental reports from inspection, as well as the self-reported health outcome 
assessments used, are subjective and imprecise, and the resulting inaccuracies are likely to have 
biased estimates for any true risk factors toward the null (i.e., toward showing no association), 
obscuring true associations.   
 
With respect to limitations in the analyses, many environmental factors of interest were too 
highly correlated to include in the same models, making it impossible to assess risks for some 
factors of interest while holding other closely related factors constant.  Many factors of interest 
did not have sufficient variation in the study buildings to include in analyses.  Finally, this 
analysis assessed many risk factor/symptom combinations, leading to the possibility of false 
positive associations occurring by chance alone (Rothman 1990).  We consider the risk factor 
variables used in the analyses to be the 72 terms for potential risk factors included in initial 
bivariate models for seven outcomes.  If no true underlying associations existed and all estimates 
were independent, chance alone would predict approximately 25 associations with p<0.05 (e. g, 
72 x 7/20) in final models. Thus, given the 21 associations with p-values <0.05 in the final 
multivariate models, at least that many false positives would be expected.  While this does not 
provide confidence in meaningful associations among the findings here, we suggest that the 
associations least likely to be false positives are those where a single risk factor is associated 
with a very large or small OR in adjusted models or with multiple biologically related symptom 
outcomes (e.g., upper respiratory symptoms with lower respiratory symptoms or cough, rather 
than, say, fatigue with skin symptoms), or where prior findings or biologic plausibility exist.  
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Many or all of the findings in this analysis, given the large number of risk factors and symptom 
outcomes investigated, may be due to chance.  Findings from this study of most potential interest 
include: the increased prevalence of lower respiratory symptoms associated with older carpets 
relative to newer ones, and the increased prevalence of upper and lower respiratory symptoms 
associated with non-carpeted floors; increased eye and skin symptoms associated with older 
furniture; increased upper respiratory, eye, and skin symptoms and headache associated with less 
frequent vacuuming; and increased cough, eye symptoms, and fatigue/concentration difficulty 
associated with masonry exterior walls.  These are all suggestive but preliminary findings.  
Replication of these results in other settings, with more precise measurements of exposure and 
response, would be necessary to confirm any of the associations reported initially in these 
analyses.   
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Appendix 1. Modeling procedures 
 
All analyses were performed using SAS version 8 (SAS Institute Inc. 2002).  We first identified 
all variables in the BASE data corresponding to risk factors of interest for this analysis: features 
or practices in buildings hypothesized to be sources of contamination.  We used data from the 
specific test space studied in each building where available and appropriate; otherwise we used 
data applicable to each building.  Additional steps in the analyses were as follows:  
 
(1) From univariate/descriptive analyses of potential risk variables, we excluded those with 
too many missing values (>10%), or insufficient variation in the key contrast (less than 
5% of observations in any key category).  We collapsed categories where appropriate, 
and in some cases created combined variables or indices that summarized risks from 
closely related or highly correlated variables, to create the initial set of risk factor 
variables.  All risk variables used in models were dichotomous or categorical.    
(2) For each of the seven symptom outcomes, we performed bivariate analyses with the 
initial risk factor variables, retaining for further analyses those with at least moderate 
associations.  For this we required an overall p-value <0.25, or for multicategorical 
variables, either an overall p-value <0.25, a p-value <0.15 for any single term or 
category, or a Mantel-Haenzsel trend p-value of <0.15.  The set of retained risk factors 
varied across the different outcome models.   
(3) For each symptom outcome, we then examined all risk variables remaining after step (2) 
together in a “risk selection” model, in order to identify and omit variables with no 
association with the outcomes when adjusted for other risk factors.  We sequentially 
excluded the variable with the highest p-value, stopping when all p-values were <0.20.  
We also identified highly correlated risk variables, and combined, revised, or eliminated 
them as necessary.   
(4) To the reduced set of risk variables in each outcome model, we added potential 
confounding variables, personal or environmental.  Potential confounders were added 
sequentially to the model, and retained if an addition changed the point estimate for any 
risk factor by at least 10%.  Selection of confounding variables was not based on 
hypothetically predicted potential for confounding (e.g., gender is included as a 
confounder, although unlikely to be systematically related to sources of contamination).   
(5) We then reconsidered previously rejected risk variables, one at a time, for contribution to 
these expanded models, retaining any with a p-value <0.05.  
(6) At this point, we examined the Hosmer-Lemeshow Goodness-of-Fit statistic.  All p-
values were >0.05 in final models.  (For any models with p-values ≤0.05, we would have 
sequentially omitted the confounder with the highest p-value until the Goodness-of-Fit p-
value >0.05.)  The final models provide adjusted estimates, as odds ratios and 95% 
confidence intervals, for the strength of association between the risk variables and the 
symptom outcomes. 
(7) Using the set of final logistic regression models for each of the seven outcomes, we then 
imputed missing values on personal variables (but not environmental or building 
variables) using SAS Proc MI (4 iterations), and re-ran the final logistic regression 
models.  Finally, we used General Estimating Equations (GEE) in SAS Proc Genmod to 
adjust for potential correlation of observations within each building.  
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Table 1. Risk factors initially considered for analyses related to contaminants from buildings and 
occupied spaces 
 
Risk Factors of Initial Interest 
Test Space-Level Factors Building-Level Factors 
 
Test Space Physical Characteristics: 
• Floor area per workstation 
• Distribution of workstations (e.g., open, 
partitioned, etc.) 
• Primary wall finish (e.g., wallpaper, fabric, 
wallboard, wood paneling, etc.) 
• Primary partition finishes 
• Primary floor finishes (e.g., carpet, wood, 
other, etc.) 
• Primary material of furniture workstations 
• Primary material of moveable furniture 
workstations 
 
Test Space-Level Pollutant Sources: 
• Smoking policy 
• Recent renovations1 
• Cleaning frequencies (e.g., general cleaning, 
dry mopping, wet mopping, vacuuming, 
etc.)1 
• Time of cleaning2 
• Cleaning materials and storage2 
• Trash storage1  
• Special use areas (e.g., with special 
processes such as print shops, graphic arts, 
labs, etc.) 1, 2 
 
Building Physical Characterization: 
• Age of building 
• Location - urban/suburban/rural 
• Neighboring land uses (e.g., agricultural, 
industrial, etc.) 
• Exterior wall construction 
 
Building-Level Pollutant Sources: 
• Outdoor contaminant sources 
• Smoking policy 
• Renovation frequency 
• Cleaning materials and storage location 
• Trash storage1 
• Pesticide use1 - internal and external 
• Pesticide use - days since last application 
• Pesticide use - location of application 
• Special use areas (e.g., with special 
processes such as print shops, graphic arts, 
labs, etc.)1 
 
  
 
1   The following risk factors were excluded before bivariate models because of missing data, inadequate variation, or 
inconsistent information, and thus were never evaluated for associations with symptoms: trash storage, pesticide 
storage, type of pesticide used, special use: restrooms, presence of dedicated vents or exhausts in special use 
areas, recent roof renovation, type of vacuum (standard/HEPA). 
2   The following variables were excluded from all outcome models after bivariate analyses: Vending room in test 
space, storage of cleaning materials in test space. 
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Table 2.  Unadjusted odds ratios (OR) and 95% confidence intervals (CI) for associations between occupant symptoms and contaminants related 
to the building or indoor space, in U.S. office buildings in the BASE study, 1994-1998 
 
    Weekly, Building-Related Symptom Outcomes 
    Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating 
Headache Irritated or Itching Skin 
Risk Factors No. of Bldgs 
No. of 
Sub-
jects 
OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Indoor Materials 
(Test Space)                   
Carpet New (Renovated in Past Year) 22 1082 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Older Than One Year 69 2845 1.79* 
1.18-
2.73 1.62* 
1.11-
2.35 1.42* 
1.18-
1.70 1.45* 
1.19-
1.76 1.54* 
1.25-
1.89 1.25* 
1.02-
1.53 1.51* 
1.04-
2.19 
  Carpet Not Primary Floor Covering 9 399 3.18* 
1.86-
5.41 2.77* 
1.70-
4.51 2.00* 
1.52-
2.62 1.74* 
1.30-
2.33 2.12* 
1.57-
2.86 1.24 
0.90-
1.71 1.69 
0.98-
2.92 
Cloth Partitions New (Renovated in Past Year) 30 1364 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
 Older Than One Year 52 2250 1.10 
0.79-
1.53 1.35 
0.98-
1.86 1.34* 
1.14-
1.59 1.20* 
1.00-
1.43 1.22* 
1.02-
1.47 1.18 
0.98-
1.43 1.10 
0.79-
1.51 
 No Cloth Partitions 18 712 0.73 0.44-1.20 0.99 
0.63-
1.56 1.06 
0.84-
1.33 1.11 
0.87-
1.40 1.12 
0.87-
1.43 0.97 
0.74-
1.26 0.97 
0.62-
1.51 
Furniture New (Renovated in Past Year) 13 632 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Older Than One Year 87 3694 1.49 
0.92-
2.41 1.71* 
1.07-
2.73 1.29* 
1.04-
1.61 1.36* 
1.07-
1.72 1.21 
0.95-
1.54 1.04 
0.82-
1.33 1.75* 
1.07-
2.86 
System Furniture No 13 549 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 87 3777 0.76 0.50-1.14 0.74 
0.51-
1.08 0.84 
0.68-
1.04 0.97 
0.77-
1.22 0.69* 
0.55-
0.87 0.91 
0.71-
1.16 0.91 
0.60-
1.38 
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    Weekly, Building-Related Symptom Outcomes 
    Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating 
Headache Irritated or Itching Skin 
Risk Factors No. of Bldgs 
No. of 
Sub-
jects 
OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Moveable 
Furniture None or Inert 44 1961 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Wood Veneer or Formica 40 1288 0.80 
0.57-
1.11 0.88 
0.65-
1.19 0.86 
0.73-
1.00 0.95 
0.81-
1.13 1.00 
0.84-
1.20 0.95 
0.79-
1.14 0.95 
0.69-
1.31 
  Other 16 664 1.04 0.68-1.57 1.08 
0.73-
1.59 0.79* 
0.63-
0.98 0.93 
0.74-
1.17 1.06 
0.84-
1.34 0.84 
0.65-
1.08 1.44 
0.98-
2.11 
Paint New (Renovated in Past Year) 26 1164 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Older Than One Year 74 3162 0.94 
0.68-
1.31 1.27 
0.91-
1.76 1.37* 
1.15-
1.63 1.23* 
1.03-
1.48 1.18 
0.98-
1.42 1.17 
0.96-
1.42 1.19 
0.85-
1.67 
Interior Wall 
Material Smooth, Inert 81 3524 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
 Smooth, Non-Inert or Unknown 15 640 0.89 
0.58-
1.37 0.84 
0.56-
1.26 0.85 
0.69-
1.06 0.85 
0.68-
1.06 0.95 
0.75-
1.19 1.04 
0.82-
1.31 0.92 
0.61-
1.39 
  Other 4 162 0.41 0.13-1.31 0.83 
0.38-
1.80 0.60* 
0.38-
0.94 0.71 
0.45-
1.11 0.97 
0.63-
1.49 0.85 
0.53-
1.35 0.65 
0.26-
1.61 
Cleaning                   
Office Cleaning 
Frequency1 Daily 86 3762 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Less than Daily 9 420 1.13 0.70-1.81 1.09 
0.70-
1.70 1.01 
0.79-
1.30 1.04 
0.80-
1.34 0.89 
0.67-
1.18 1.21 
0.93-
1.58 1.02 
0.64-
1.65 
  As Needed or Missing 5 144 0.32 
0.08-
1.29 0.54 
0.20-
1.47 0.60* 
0.37-
0.96 0.52* 
0.30-
0.89 0.81 
0.50-
1.30 0.43* 
0.22-
0.82 0.43 
0.14-
1.36 
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    Weekly, Building-Related Symptom Outcomes 
    Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating 
Headache Irritated or Itching Skin 
Risk Factors No. of Bldgs 
No. of 
Sub-
jects 
OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Office Cleaning in 
Occupied Hours No 85 3762 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 15 654 1.26 0.86-1.86 1.22 
0.85-
1.75 1.10 
0.90-
1.35 1.14 
0.93-
1.41 1.24 
1.00-
1.53 1.14 
0.91-
1.43 1.36 
0.94-
1.95 
Dry Mopping 
Frequency None 29 1077 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Daily to Biweekly 63 2882 1.14 0.80-1.64 1.18 
0.85-
1.64 1.19 
1.00-
1.42 1.14 
0.95-
1.37 1.23* 
1.01-
1.49 1.01 
0.83-
1.23 1.10 
0.78-
1.55 
  As Needed or Missing 8 367 1.15 
0.64-
2.07 0.59 
0.30-
1.18 0.80 
0.58-
1.09 0.86 
0.62-
1.19 1.18 
0.86-
1.63 0.90 
0.64-
1.27 1.08 
0.61-
1.90 
Dry Mopping in 
Occupied Hours No 86 3707 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 14 619 1.19 0.80-1.78 1.30 
0.91-
1.86 1.14 
0.93-
1.40 1.06 
0.85-
1.32 1.11 
0.88-
1.39 1.10 
0.87-
1.39 1.22 
0.83-
1.79 
Wet Mopping 
Frequency None 8 297 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Daily 76 3367 1.19 0.64-2.22 1.16 
0.65-
2.06 1.05 
0.79-
1.41 1.03 
0.76-
1.41 0.71* 
0.53-
0.95 0.80 
0.59-
1.09 1.63 
0.82-
3.22 
  Weekly-to-Monthly 11 439 0.91 0.41-2.02 0.83 
0.39-
1.75 0.61* 
0.41-
0.90 0.82 
0.56-
1.22 0.50* 
0.33-
0.74 0.52* 
0.34-
0.79 1.04 
0.44-
2.43 
  As Needed or Missing 5 223 0.96 
0.38-
2.43 1.67 
0.79-
3.55 0.98 
0.64-
1.50 0.92 
0.58-
1.46 0.79 
0.51-
1.23 0.87 
0.55-
1.38 1.64 
0.67-
4.02 
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    Weekly, Building-Related Symptom Outcomes 
    Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating 
Headache Irritated or Itching Skin 
Risk Factors No. of Bldgs 
No. of 
Sub-
jects 
OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Wet Mopping in 
Occupied Hours No 80 3503 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 20 823 1.21 0.84-1.73 1.09 
0.78-
1.54 1.01 
0.84-
1.21 1.02 
0.84-
1.24 1.14 
0.93-
1.39 1.07 
0.86-
1.31 1.19 
0.84-
1.68 
Vacuuming 
Frequency Daily 73 3027 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Weekly to Monthly 19 1018 1.22 0.87-1.70 1.55* 
1.15-
2.08 1.39* 
1.18-
1.65 1.37* 
1.15-
1.64 1.35* 
1.12-
1.62 1.38* 
1.14-
1.67 1.44* 
1.05-
1.96 
  As Needed or Missing 8 281 0.51 
0.22-
1.16 0.79 
0.41-
1.51 0.92 
0.67-
1.26 0.85 
0.60-
1.20 0.88 
0.62-
1.25 0.93 
0.65-
1.33 0.39* 
0.16-
0.97 
Vacuuming in 
Occupied Hours No 85 3693 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 15 633 1.02 0.67-1.55 0.98 
0.66-
1.45 1.03 
0.83-
1.26 1.15 
0.93-
1.42 1.10 
0.88-
1.38 1.05 
0.83-
1.32 1.13 
0.77-
1.66 
Cleaning materials 
stored in test space No 46 2022 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 52 2228 1.05 0.78-1.41 1.08 
0.82-
1.42 1.02 
0.88-
1.18 1.00 
0.85-
1.16 1.08 
0.92-
1.27 0.99 
0.83-
1.17 0.87 
0.65-
1.16 
Window cleaner 
used No 25 1017 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 75 3309 1.66* 1.11-2.48 1.33 
0.94-
1.88 0.98 
0.82-
1.16 1.05 
0.87-
1.26 0.89 
0.74-
1.07 1.01 
0.83-
1.23 0.91 
0.65-
1.26 
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    Weekly, Building-Related Symptom Outcomes 
    Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating 
Headache Irritated or Itching Skin 
Risk Factors No. of Bldgs 
No. of 
Sub-
jects 
OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Furniture cleaner 
used No 50 2097 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 50 2229 1.39* 1.03-1.88 1.13 
0.86-
1.49 1.02 
0.88-
1.18 1.07 
0.91-
1.25 0.93 
0.79-
1.09 0.96 
0.81-
1.14 0.93 
0.70-
1.24 
Floor wax used No 57 2374 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 43 1952 1.04 0.77-1.40 0.88 
0.67-
1.16 0.87 
0.75-
1.01 0.81* 
0.69-
0.94 0.91 
0.78-
1.08 0.91 
0.77-
1.08 0.95 
0.71-
1.26 
Bathroom cleaner 
used No 22 854 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 78 3472 2.17* 1.34-3.51 1.29 
0.89-
1.86 1.05 
0.88-
1.27 1.11 
0.91-
1.35 0.96 
0.78-
1.17 1.10 
0.89-
1.37 1.04 
0.72-
1.49 
Bleach used No 73 3190 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 27 1136 0.89 0.63-1.26 0.77 
0.55-
1.07 0.83* 
0.70-
0.98 0.97 
0.81-
1.15 0.84 
0.69-
1.01 0.99 
0.82-
1.20 0.90 
0.64-
1.25 
Liquid soap used No 31 1230 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 69 3096 1.76* 1.21-2.58 0.90 
0.67-
1.21 0.93 
0.79-
1.09 0.99 
0.83-
1.17 0.97 
0.81-
1.16 0.96 
0.80-
1.15 1.12 
0.81-
1.56 
Carpet cleaner 
used No 39 1678 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 61 2648 1.15 0.84-1.56 0.77 
0.58-
1.01 0.80* 
0.69-
0.93 0.92 
0.79-
1.08 0.79* 
0.67-
0.93 0.90 
0.76-
1.07 0.97 
0.72-
1.30 
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    Weekly, Building-Related Symptom Outcomes 
    Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating 
Headache Irritated or Itching Skin 
Risk Factors No. of Bldgs 
No. of 
Sub-
jects 
OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Other cleaner used No 13 566 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 87 3760 1.23 0.77-1.97 1.16 
0.76-
1.77 1.11 
0.89-
1.39 1.06 
0.84-
1.34 0.94 
0.74-
1.19 0.84 
0.66-
1.06 0.71 
0.48-
1.04 
Pesticides                   
Exterior Pesticide 
Application 
Frequency 
None 33 1356 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Daily to Monthly 15 601 0.80 0.48-1.32 0.64 
0.39-
1.04 0.82 
0.64-
1.05 0.92 
0.71-
1.19 0.76* 
0.58-
0.99 0.97 
0.74-
1.28 0.83 
0.51-
1.38 
  Semi-quarterly to Annually 17 805 0.76 
0.48-
1.21 0.84 
0.57-
1.25 1.18 
0.96-
1.46 1.13 
0.90-
1.41 1.13 
0.91-
1.42 1.15 
0.90-
1.46 1.54* 
1.05-
2.25 
  As Needed or Missing 35 1564 1.11 
0.78-
1.57 0.88 
0.64-
1.22 0.98 
0.82-
1.18 1.07 
0.89-
1.30 0.89 
0.73-
1.08 1.00 
0.81-
1.23 0.94 
0.65-
1.35 
Interior Pesticide 
Application 
Frequency 
None 15 634 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Daily to Biweekly 5 184 0.78 0.29-2.09 1.19 
0.55-
2.59 0.90 
0.58-
1.41 1.41 
0.92-
2.18 1.07 
0.65-
1.76 1.14 
0.70-
1.87 0.84 
0.34-
2.10 
  Monthly to Semi-Annually 43 1939 1.26 
0.78-
2.03 1.19 
0.76-
1.86 1.24 
0.98-
1.56 1.26 
0.98-
1.62 1.56* 
1.19-
2.03 1.32* 
1.00-
1.74 1.27 
0.80-
2.01 
  As Needed or Missing 37 1569 1.32 
0.81-
2.15 1.34 
0.85-
2.09 1.47* 
1.16-
1.86 1.58* 
1.23-
2.04 1.59* 
1.21-
2.09 1.51* 
1.15-
2.00 1.27 
0.79-
2.03 
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    Weekly, Building-Related Symptom Outcomes 
    Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating 
Headache Irritated or Itching Skin 
Risk Factors No. of Bldgs 
No. of 
Sub-
jects 
OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Exterior Pesticide, 
Duration Since 
Last Application 
None 42 1719 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Four Months or More 20 907 0.72 
0.47-
1.12 1.13 
0.80-
1.61 1.25* 
1.03-
1.52 1.11 
0.90-
1.36 1.13 
0.92-
1.40 1.04 
0.83-
1.31 1.18 
0.80-
1.72 
  Zero to Three Months 38 1700 1.05 
0.76-
1.46 0.87 
0.64-
1.20 0.90 
0.76-
1.06 1.01 
0.85-
1.21 0.90 
0.75-
1.09 1.00 
0.83-
1.21 1.10 
0.80-
1.53 
Interior Pesticide, 
Duration Since 
Last Application 
None 28 1122 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Four Months or More 11 580 1.58 
0.98-
2.54 1.65* 
1.07-
2.53 1.89* 
1.49-
2.39 1.61* 
1.25-
2.07 1.87* 
1.44-
2.42 1.58* 
1.20-
2.07 1.35 
0.86-
2.13 
  Zero to Three Months 61 2624 1.18 
0.82-
1.71 1.09 
0.78-
1.53 1.17 
0.97-
1.39 1.20 
0.99-
1.44 1.22 
1.00-
1.49 1.18 
0.96-
1.45 1.04 
0.74-
1.47 
Location of 
Interior Pesticide 
Use 
None in Building 25 982 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  In Building, but Outside Test Space 20 849 0.98 
0.58-
1.64 1.08 
0.70-
1.66 1.05 
0.83-
1.32 1.10 
0.86-
1.41 1.12 
0.87-
1.44 1.17 
0.90-
1.52 1.10 
0.69-
1.76 
  Including Test Space 55 2495 1.54* 
1.04-
2.29 1.14 
0.80-
1.61 1.22* 
1.01-
1.47 1.27* 
1.05-
1.55 1.17 
0.95-
1.44 1.15 
0.93-
1.42 1.29 
0.89-
1.88 
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    Weekly, Building-Related Symptom Outcomes 
    Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating 
Headache Irritated or Itching Skin 
Risk Factors No. of Bldgs 
No. of 
Sub-
jects 
OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Special Uses 
(Study Space)                   
Kitchenette No 32 1417 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 68 2909 0.70* 0.52-0.95 0.59* 
0.45-
0.78 0.81* 
0.69-
0.94 0.86 
0.73-
1.01 0.66* 
0.56-
0.78 0.82* 
0.69-
0.97 0.73* 
0.55-
0.98 
Vending Room No 72 3030 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 28 1296 1.01 0.73-1.40 1.03 
0.76-
1.39 1.08 
0.92-
1.27 0.97 
0.82-
1.15 0.99 
0.83-
1.18 1.07 
0.89-
1.28 1.06 
0.78-
1.45 
Print Shop No 92 3996 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 8 330 1.17 0.69-1.98 1.10 
0.67-
1.81 0.85 
0.64-
1.13 0.74 
0.54-
1.01 1.17 
0.87-
1.56 1.08 
0.79-
1.47 1.45 
0.91-
2.32 
Graphics Room No 90 3870 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 10 456 0.43* 0.22-0.85 0.82 
0.50-
1.32 1.01 
0.80-
1.28 0.87 
0.67-
1.13 1.05 
0.81-
1.36 0.97 
0.74-
1.27 1.01 
0.64-
1.61 
Computer Room No 58 2451 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 42 1875 0.96 0.71-1.29 1.04 
0.79-
1.37 1.20* 
1.03-
1.38 1.25* 
1.07-
1.46 1.10 
0.94-
1.29 1.19* 
1.01-
1.41 1.23 
0.92-
1.63 
Conference Room No 27 1231 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 73 3095 0.84 0.61-1.16 0.84 
0.63-
1.13 1.11 
0.94-
1.31 1.14 
0.96-
1.36 0.94 
0.79-
1.12 0.96 
0.79-
1.15 0.82 
0.61-
1.12 
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    Weekly, Building-Related Symptom Outcomes 
    Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating 
Headache Irritated or Itching Skin 
Risk Factors No. of Bldgs 
No. of 
Sub-
jects 
OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Special Uses 
(building)                   
Lab Facility No 66 2874 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 34 1452 1.16 0.85-1.58 1.12 
0.85-
1.50 0.88 
0.75-
1.02 0.94 
0.80-
1.11 0.87 
0.73-
1.04 0.82* 
0.68-
0.98 0.97 
0.71-
1.31 
Commercial 
kitchen No 99 4269 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 11 57 1.22 0.90-1.64 0.97 
0.74-
1.28 0.86* 
0.74-
1.00 0.99 
0.84-
1.15 0.99 
0.84-
1.16 0.97 
0.82-
1.14 1.09 
0.82-
1.45 
Parking Garage No 63 2718 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 37 1608 0.96 0.71-1.31 1.02 
0.77-
1.35 1.01 
0.87-
1.17 1.00 
0.85-
1.17 1.11 
0.94-
1.30 1.07 
0.90-
1.27 1.31 
0.98-
1.75 
Loading Docks No 27 1078 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 73 3248 1.04 0.74-1.48 1.13 
0.82-
1.57 1.24* 
1.04-
1.47 1.17 
0.98-
1.41 1.08 
0.89-
1.30 1.24* 
1.01-
1.51 1.06 
0.76-
1.49 
Building 
Characteristics                   
Year of Building 
Construction 1850-1945 23 845 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
 1946-1975 36 1686 1.55* 1.00- 2.39 1.42 
0.98-
2.06 1.21 
0.99 - 
1.47 1.44* 
1.16 - 
1.78 1.07 
0.86 - 
1.33 1.21 
0.96- 
1.52 1.29 
0.87-
1.93 
 1976-1996 41 1795 1.17 0.75-1.83 0.78 
0.52-
1.16 0.81* 
0.66-
0.99 0.96 
0.77 - 
1.20 0.78* 
0.63-
0.98 0.86 
0.68-
1.09 0.97 
0.65-
1.47 
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    Weekly, Building-Related Symptom Outcomes 
    Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating 
Headache Irritated or Itching Skin 
Risk Factors No. of Bldgs 
No. of 
Sub-
jects 
OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Building Location Suburban 23 1120 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Urban 73 3044 0.76 0.55-1.05 1.02 
0.74-
1.40 0.91 
0.77-
1.07 0.86 
0.72-
1.02 0.92 
0.77-
1.10 0.93 
0.77-
1.13 0.88 
0.64-
1.22 
  Rural 4 162 1.12 0.54-2.30 0.73 
0.31-
1.73 0.64* 
0.41-
1.00 0.92 
0.60-
1.40 0.63 
0.38-
1.04 0.86 
0.53-
1.38 0.59 
0.23-
1.49 
Neighboring Land 
Use Residential 15 636 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Commercial 73 3158 0.84 0.57-1.26 1.08 
0.73-
1.60 0.91 
0.74-
1.11 1.08 
0.87-
1.36 0.95 
0.76-
1.19 1.04 
0.82-
1.33 0.96 
0.65-
1.42 
  Other2 12 532 0.76 0.43-1.36 0.81 
0.46-
1.44 0.60* 
0.45-
0.81 1.04 
0.77-
1.41 0.67* 
0.48-
0.92 0.86 
0.61-
1.20 0.51* 
0.27-
0.96 
Exterior Wall 
Material Masonry 45 1861 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Glass/Metal Curtain 15 665 0.90 
0.57-
1.41 0.46* 
0.28-
0.76 0.70* 
0.56-
0.88 0.67* 
0.52-
0.87 0.75* 
0.58-
0.96 0.92 
0.71-
1.19 0.90 
0.59-
1.37 
  Stone or Precast Concrete Panels 33 1556 0.99 
0.71-
1.38 0.86 
0.64-
1.16 0.93 
0.79-
1.09 1.12 
0.94-
1.33 0.94 
0.79-
1.13 1.13 
0.94-
1.36 0.86 
0.62-
1.19 
  Other3 7 244 0.74 0.36-1.56 0.26* 
0.09-
0.71 0.53* 
0.36-
0.77 0.58* 
0.38-
0.86 0.55* 
0.36-
0.85 0.75 
0.49-
1.13 0.54 
0.25-
1.19 
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    Weekly, Building-Related Symptom Outcomes 
    Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating 
Headache Irritated or Itching Skin 
Risk Factors No. of Bldgs 
No. of 
Sub-
jects 
OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Smoking Policy No Smoking in Building 71 2960 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  
Smoking Permitted 
in Smoking 
Lounges outside 
Test Space 
20 940 1.15 0.80-1.64 1.25 
0.91-
1.72 1.08 
0.90-
1.29 1.20 
1.00-
1.44 1.34* 
1.11-
1.62 1.38* 
1.14-
1.68 1.36 
0.98-
1.90 
  Smoking Permitted in Test Space 9 426 1.17 
0.72-
1.91 1.05 
0.65-
1.68 0.84 
0.65-
1.09 0.86 
0.65-
1.13 1.00 
0.76-
1.32 0.77 
0.56-
1.06 1.37 
0.87-
2.15 
Outdoor Sources 
in proximity                   
Garbage 
dumpsters No 19 868 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 81 3458 0.73 0.52-1.03 1.15 
0.80-
1.64 1.00 
0.83-
1.20 1.06 
0.87-
1.29 0.88 
0.72-
1.07 1.07 
0.86-
1.32 1.01 
0.71-
1.45 
Heavy vehicle 
traffic No 39 1660 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 61 2666 1.10 0.81-1.50 1.11 
0.83-
1.47 1.00 
0.86-
1.16 1.11 
0.95-
1.31 1.11 
0.94-
1.31 1.17 
0.98-
1.39 1.16 
0.86-
1.56 
Emergency 
generators No 34 1371 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 66 2955 1.39 0.99-1.96 1.38* 
1.01-
1.89 1.14 
0.97-
1.33 1.10 
0.93-
1.30 1.25* 
1.04-
1.49 1.07 
0.89-
1.28 1.02 
0.75-
1.38 
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    Weekly, Building-Related Symptom Outcomes 
    Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating 
Headache Irritated or Itching Skin 
Risk Factors No. of Bldgs 
No. of 
Sub-
jects 
OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Power plants No 74 3226 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 26 1100 0.74 0.51-1.07 0.90 
0.65-
1.24 0.90 
0.75-
1.06 0.91 
0.76-
1.09 0.84 
0.69-
1.02 0.89 
0.73-
1.09 1.08 
0.78-
1.49 
Construction sites No 44 1950 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 56 2376 0.89 0.66-1.20 0.78 
0.59-
1.02 0.83* 
0.72-
0.96 0.96 
0.82-
1.12 1.02 
0.86-
1.20 0.99 
0.84-
1.18 1.06 
0.79-
1.41 
Industrial or 
medical stacks No 65 2839 1.00  1.00  1.00  1.00  1.00  1.00  1.00  
  Yes 35 1487 0.75 0.54-1.05 0.97 
0.73-
1.30 0.96 
0.82-
1.12 1.02 
0.87-
1.20 0.84 
0.71-
1.00 0.96 
0.80-
1.15 0.93 
0.69-
1.26 
 
*  P-value <0.05 
1    schedule for typical office cleaning such as straightening, tidying, and dusting 
2  “Other” neighboring land uses included agricultural and industrial. 
3  “Other” exterior wall materials included exterior insulation finish; siding on frame; metal building system; stucco exterior; aluminum panels over honeycomb insulation; 
steel frame, styrofoam and stucco; and quartzite blocks. 
 
  30 
 
 
Table 3.  Adjusted odds ratios (ORs) and 95% confidence intervals (CIs), from logistic regression models1 with generalized estimating equations, 
for associations between occupant symptoms and risk factors for contaminants from buildings or indoor spaces in U.S. office buildings in the 
BASE study, 1994-1998  
 
  Weekly, Building-Related Symptom Outcomes 
  Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating
Headache Irritated or Itching Skin 
Risk Factors  OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Indoor Materials 
(Test Space)                 
Carpet New Carpet (Renovated in Past Year) 1.00    1.00          
  Carpet Older Than One Year 1.87* 1.18-2.96   1.09 
0.87-
1.37         
  Carpet Not Primary Floor Covering 2.34* 
1.31-
4.17   2.24* 
1.68-
3.00         
Cloth Partitions New (Renovated in Past Year)       1.00        
 Older Than One Year       0.93 0.75-1.15       
 No Cloth Partitions       0.91 0.68-1.21       
Furniture New (Renovated in Past Year)       1.00      1.00  
  Older Than One Year       1.42* 1.06-1.90     2.06* 
1.21-
3.49 
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  Weekly, Building-Related Symptom Outcomes 
  Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating
Headache Irritated or Itching Skin 
Risk Factors  OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Interior Wall Material Smooth, Inert       1.00        
  Smooth, Non-Inert or Unknown       1.23 
0.93-
1.62       
  Other       0.75 0.43-1.30       
Cleaning                 
Dry Mopping 
Frequency None       1.00        
  Daily to Biweekly       1.07 0.86-1.32       
  As Needed or Missing       0.71 0.46-1.08       
Wet Mopping 
Frequency None           1.00    
  Daily           0.77 0.56-1.07   
  Weekly-to-Monthly           0.46* 0.29-0.72   
  As Needed or Missing           0.89 0.54-1.49   
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  Weekly, Building-Related Symptom Outcomes 
  Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating
Headache Irritated or Itching Skin 
Risk Factors  OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Vacuuming Frequency Daily     1.00  1.00    1.00  1.00  
  Weekly to Monthly     1.38* 1.13-1.68 1.30* 
1.05-
1.61   1.42* 
1.14-
1.76 1.37 
1.00-
1.88 
  As Needed or Missing     1.24 0.84-1.84 0.84 
0.56-
1.26   0.97 
0.66-
1.43 0.30* 
0.12-
0.76 
Window cleaner used No     1.00          
  Yes     0.72* 0.54-0.97         
Bathroom cleaner used No 1.00    1.00          
  Yes 2.29* 1.40-3.75   1.31 
0.95-
1.80         
Carpet cleaner used No           1.00    
  Yes           0.88 0.73-1.06   
Cleaning materials 
stored in test space 
 
No 
    1.00          
 Yes     0.93 0.77-1.13         
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  Weekly, Building-Related Symptom Outcomes 
  Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating
Headache Irritated or Itching Skin 
Risk Factors  OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Pesticides                 
Exterior Pesticide 
Application 
Frequency 
None     1.00          
  Daily to Monthly     1.14 0.85-1.52         
  Semiquarterly to Annually     1.44* 1.12-1.85         
  As Needed or Missing     1.09 0.87-1.36         
Exterior Pesticide, 
Duration Since Last 
Application 
None           1.00    
  Four Months or More           0.95 0.75-1.21   
  Zero to Three Months           1.10 0.90-1.36   
Interior Pesticide, 
Duration Since 
Last Application 
None     1.00  1.00  1.00  1.00    
  Four Months or More     1.79* 1.32-2.41   1.70* 
1.31-
2.21 1.57* 
1.15-
2.15   
  Zero to Three Months     1.19 0.95-1.49   1.22 
0.98-
1.50 1.19 
0.95-
1.49   
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  Weekly, Building-Related Symptom Outcomes 
  Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating
Headache Irritated or Itching Skin 
Risk Factors  OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Special Uses (Study 
Space)                 
Kitchenette No   1.00      1.00      
  Yes   0.75 0.55-1.02     0.70* 
0.59-
0.84     
Vending Room No     1.00    1.00      
 Yes     1.16 0.95-1.41   1.07 
0.89-
1.29     
Special Uses 
(building)                 
Lab Facility No     1.00          
  Yes     1.01 0.84-1.22         
Parking Garage No     1.00          
  Yes     0.90 0.74-1.09         
Loading Docks No         1.00      
 Yes         1.04 0.84-1.28     
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  Weekly, Building-Related Symptom Outcomes 
  Lower Respiratory Cough 
Upper 
Respiratory 
Irritated or 
Itching Eyes 
Fatigue or 
Difficulty 
Concentrating
Headache Irritated or Itching Skin 
Risk Factors  OR 95% CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI OR 
95% 
CI 
Building 
Characteristics          
Exterior Wall Material Masonry   1.00    1.00  1.00      
  Glass/Metal Curtain   0.47* 0.28-0.81   0.64* 
0.48-
0.85 0.87 
0.66-
1.14     
  Stone or Precast Concrete Panels   0.76 
0.54-
1.05   1.10 
0.91-
1.33 0.94 
0.77-
1.14     
  Other   0.36 0.13-1.01   0.43* 
0.28-
0.67 0.63* 
0.41-
0.97     
Smoking Policy No Smoking in Building             1.00  
  
Smoking Permitted in 
Smoking Lounges outside 
Test Space 
            1.14 0.81-1.60 
  Smoking Permitted in Test Space             1.84* 
1.14-
2.98 
Number of buildings in final model 92 92 92 92 100 100 92 
Number of observations (occupants) in final model 4005 3952 3997 3937 4313 4249 3897 
 
*  P-value <0.05 
1  For each of the seven symptom outcomes, all potential  risk factors in this Table were included simultaneously in one model, along with confounding variables selected 
during model construction. Potential confounding variables included environmental variables (temperature, humidity, ventilation rate,  occupant density, area per operable 
window, season of study) and personal variables (gender, age, education, smoking status, asthma, mold allergy, dust allergy, eczema, hay fever, type of workstation, 
comfort of chair, satisfaction with work station, job satisfaction, job demand, job conflict, hours worked per week,  photocopier use, hours working at a computer,  and 
years worked in building). 
 
